Genetic testing for homologous recombination repair (HRR) in metastatic castration-resistant prostate cancer (mCRPC): challenges
HRR gene alterations (deleterious somatic or germline) tested in major... | Download Scientific Diagram
JPM | Free Full-Text | Homologous Recombination Deficiency in Ovarian Cancer: from the Biological Rationale to Current Diagnostic Approaches
Webinar on Significance of HRR gene testing in Prostate and Ovarian Cancer - YouTube
SOPHiA DDM™ Homologous Recombination Applications - SOPHiA GENETICS
Challenges in next generation sequencing of homology recombination repair genomic variants in prostate cancer: A nationwide survey and calibration project in China - ScienceDirect
Pathologic HRR gene mutations of paired ovarian cancer samples | Download Scientific Diagram
Landscape of germline and somatic alterations of HRR and MMR genes in 328 Chinese patients with primary epithelial ovarian cancer(EOC) - Gynecologic Oncology
Data May Support Routine Tumor Testing for HRR Gene Alterations in mCRPC - Renal and Urology News
Homologous recombination repair | QIAseq HRR panel | DNA damage response
JPM | Free Full-Text | Biomarkers for Homologous Recombination Deficiency in Cancer
HRR genes alterations (PROfound genes) are highly represented and the... | Download Scientific Diagram
Precision Medicine for HRRm Testing in Prostate Cancer | AstraZeneca
Homologous recombination repair gene mutations show no survival benefits in Chinese high-grade serous ovarian cancer patients - Feng - Annals of Translational Medicine
ESMO 2019: Central, Prospective Detection of Homologous Recombination Repair Gene Mutations (HRRm) in Tumour Tissue from >4000 Men with mCRPC Screened for the PROfound Study
ESMO 2019: Central, Prospective Detection of Homologous Recombination Repair Gene Mutations (HRRm) in Tumour Tissue from >4000 Men with mCRPC Screened for the PROfound Study
Candidate biomarkers of PARP inhibitor sensitivity in ovarian cancer beyond the BRCA genes | British Journal of Cancer
Truly Comprehensive Genomic Profiling
Homologous recombination repair deficiency (HRD): From biology to clinical exploitation - Gonzalez - 2021 - Genes, Chromosomes and Cancer - Wiley Online Library
ASCO 2022: Gene-by-Gene Analysis in the MAGNITUDE Study of Niraparib (NIRA) with Abiraterone Acetate and Prednisone (AAP) in Patients with Metastatic Castration-Resistant Prostate Cancer (mCRPC) and Homologous Recombination Repair (HRR) Gene Alterations.
Frontiers | Homologous Recombination Deficiency Assays in Epithelial Ovarian Cancer: Current Status and Future Direction
Frontiers | Tumor Genotyping and Homologous Recombination Repair Gene Variants in Patients With Epithelial Ovarian Cancer: Is Pathogenic Enough?
Genetic testing for homologous recombination repair (HRR) in metastatic castration-resistant prostate cancer (mCRPC): challenges and solutions | Oncotarget
Homologous recombination proficiency in ovarian and breast cancer patients | BMC Cancer | Full Text
The mutational pattern of homologous recombination-related (HRR) genes in Chinese colon cancer and its relevance to immunotherapy responses | Aging
Frontiers | Mutation Landscape of Homologous Recombination Repair Genes in Epithelial Ovarian Cancer in China and Its Relationship With Clinicopathlological Characteristics
